Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Amgen eyes potential acquisitions

Executive Summary

Amgen's consolidation of Immunex gives the company confidence that it could pursue other large agreements, CEO Sharer said Feb. 25, but "that doesn't mean we're just going to [do] it for the heck of it." While "acquisitions are something that we don't expect," Sharer says, "obviously, given that prices are much lower right now, we're looking harder." The CEO outlined Amgen's criteria for a takeover prospect, which include an ability to drive top-line growth and a fit with Amgen's culture...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS041336

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel